You can:
Name | Somatostatin receptor type 3 |
---|---|
Species | Homo sapiens (Human) |
Gene | SSTR3 |
Synonym | SSR-28 SS3R SS3-R SS-3-R SRIF1C [ Show all ] |
Disease | N/A |
Length | 418 |
Amino acid sequence | MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL |
UniProt | P32745 |
Protein Data Bank | N/A |
GPCR-HGmod model | P32745 |
3D structure model | This predicted structure model is from GPCR-EXP P32745. |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL2028 |
IUPHAR | 357 |
DrugBank | BE0003529 |
Name | CHEMBL2204940 |
---|---|
Molecular formula | C26H21FN8O2 |
IUPAC name | 3-[(3R)-3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]-1-(5-methyl-1,2,4-oxadiazol-3-yl)-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]-5-methyl-1,2,4-oxadiazole |
Molecular weight | 496.506 |
Hydrogen bond acceptor | 9 |
Hydrogen bond donor | 3 |
XlogP | 3.4 |
Synonyms | BDBM50400523 |
Inchi Key | HDVFNFJNBVGCNA-HXUWFJFHSA-N |
Inchi ID | InChI=1S/C26H21FN8O2/c1-13-29-24(34-36-13)26(25-30-14(2)37-35-25)22-18(17-5-3-4-6-19(17)31-22)11-20(33-26)23-28-12-21(32-23)15-7-9-16(27)10-8-15/h3-10,12,20,31,33H,11H2,1-2H3,(H,28,32)/t20-/m1/s1 |
PubChem CID | 71461260 |
ChEMBL | CHEMBL2204940 |
IUPHAR | N/A |
BindingDB | 50400523 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 0.97 nM | PMID24900499 | BindingDB |
IC50 | 0.97 nM | PMID24900499 | ChEMBL |
IC50 | 1.2 nM | PMID24900499 | BindingDB,ChEMBL |
Inhibition | 69.0 % | PMID24900499 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417